Horikawa C, Tsuda K, Oshida Y, Satoh J, Hayashino Y, Tajima N
Diabetol Int. 2022; 13(2):344-357.
PMID: 35463859
PMC: 8980175.
DOI: 10.1007/s13340-022-00575-0.
Coe C, Tsenkova V, Love G, Kawakami N, Karasawa M, Kitayama S
Arch Epidemiol. 2022; 4.
PMID: 35425890
PMC: 9007276.
DOI: 10.29011/2577-2252.100042.
Tatsukawa Y, Cordova K, Yamada M, Ohishi W, Imaizumi M, Hida A
J Clin Endocrinol Metab. 2021; 107(5):e2148-e2155.
PMID: 34918116
PMC: 9016441.
DOI: 10.1210/clinem/dgab902.
Takeuchi M, Horikawa C, Hatta M, Takeda Y, Nedachi R, Ikeda I
Nutrients. 2021; 13(10).
PMID: 34684444
PMC: 8538089.
DOI: 10.3390/nu13103428.
Tateishi R, Matsumura T, Okanoue T, Shima T, Uchino K, Fujiwara N
J Gastroenterol. 2021; 56(3):261-273.
PMID: 33427937
PMC: 7932951.
DOI: 10.1007/s00535-020-01754-z.
Influence of different diagnostic criteria on gestational diabetes mellitus incidence and medical expenditures in China.
He Z, Xie H, Liang S, Tang Y, Ding W, Wu Y
J Diabetes Investig. 2019; 10(5):1347-1357.
PMID: 30663279
PMC: 6717806.
DOI: 10.1111/jdi.13008.
Impact of fish consumption by subjects with prediabetes on the metabolic risk factors: using data in the 2015 (6th) Korea National Health and Nutrition Examination Surveys.
Kim K, Park J
Nutr Res Pract. 2018; 12(3):233-242.
PMID: 29854329
PMC: 5974069.
DOI: 10.4162/nrp.2018.12.3.233.
The prevalence and risk factor control associated with noncommunicable diseases in China, Japan, and Korea.
Ma D, Sakai H, Wakabayashi C, Kwon J, Lee Y, Liu S
J Epidemiol. 2017; 27(12):568-573.
PMID: 28623056
PMC: 5623033.
DOI: 10.1016/j.je.2016.12.019.
Insulin degludec/insulin aspart vs biphasic insulin aspart 30 twice daily in Japanese patients with type 2 diabetes: A randomized controlled trial.
Onishi Y, Yamada K, Zacho J, Ekelund J, Iwamoto Y
J Diabetes Investig. 2016; 8(2):210-217.
PMID: 27560769
PMC: 5334300.
DOI: 10.1111/jdi.12569.
Efficacy and Safety of Vildagliptin as an Add-on to Insulin with or without Metformin in Japanese Patients with Type 2 Diabetes Mellitus: A 12-week, Double-Blind, Randomized Study.
Hirose T, Suzuki M, Tsumiyama I
Diabetes Ther. 2015; 6(4):559-571.
PMID: 26620049
PMC: 4674469.
DOI: 10.1007/s13300-015-0147-6.
Trend and risk factors of diverticulosis in Japan: age, gender, and lifestyle/metabolic-related factors may cooperatively affect on the colorectal diverticula formation.
Yamamichi N, Shimamoto T, Takahashi Y, Sakaguchi Y, Kakimoto H, Matsuda R
PLoS One. 2015; 10(4):e0123688.
PMID: 25860671
PMC: 4393308.
DOI: 10.1371/journal.pone.0123688.
Profile of saxagliptin in the treatment of type 2 diabetes: focus on Japanese patients.
Konya H, Yano Y, Matsutani S, Tsunoda T, Ikawa T, Kusunoki Y
Ther Clin Risk Manag. 2014; 10:547-58.
PMID: 25050065
PMC: 4103926.
DOI: 10.2147/TCRM.S46076.
The once-daily human glucagon-like peptide-1 analog, liraglutide, improves β-cell function in Japanese patients with type 2 diabetes.
Seino Y, Rasmussen M, Clauson P, Kaku K
J Diabetes Investig. 2014; 3(4):388-95.
PMID: 24843595
PMC: 4019260.
DOI: 10.1111/j.2040-1124.2012.00193.x.
Long-term safety and efficacy of exenatide twice daily in Japanese patients with suboptimally controlled type 2 diabetes.
Inagaki N, Ueki K, Yamamura A, Saito H, Imaoka T
J Diabetes Investig. 2014; 2(6):448-56.
PMID: 24843529
PMC: 4014904.
DOI: 10.1111/j.2040-1124.2011.00137.x.
Improved glycemic control and reduced bodyweight with exenatide: A double-blind, randomized, phase 3 study in Japanese patients with suboptimally controlled type 2 diabetes over 24 weeks.
Kadowaki T, Namba M, Imaoka T, Yamamura A, Goto W, Boardman M
J Diabetes Investig. 2014; 2(3):210-7.
PMID: 24843486
PMC: 4014921.
DOI: 10.1111/j.2040-1124.2010.00084.x.
Comparative effectiveness of dipeptidyl peptidase-4 (DPP-4) inhibitors and human glucagon-like peptide-1 (GLP-1) analogue as add-on therapies to sulphonylurea among diabetes patients in the Asia-Pacific region: a systematic review.
Wong M, Wang H, Kwan M, Zhang D, Liu K, Chan S
PLoS One. 2014; 9(3):e90963.
PMID: 24614606
PMC: 3948731.
DOI: 10.1371/journal.pone.0090963.
Efficacy and Safety of Vildagliptin as Add-on to Metformin in Japanese Patients with Type 2 Diabetes Mellitus.
Odawara M, Hamada I, Suzuki M
Diabetes Ther. 2014; 5(1):169-81.
PMID: 24604395
PMC: 4065285.
DOI: 10.1007/s13300-014-0059-x.
Increasing prevalence of diabetes mellitus in association with fatty liver in a Japanese population.
Imamura Y, Uto H, Hiramine Y, Hosoyamada K, Ijuin S, Yoshifuku S
J Gastroenterol. 2013; 49(10):1406-13.
PMID: 24170184
DOI: 10.1007/s00535-013-0902-2.
Effects of mitiglinide, a short-acting insulin secretagogue, on daily glycemic variability and oxidative stress markers in Japanese patients with type 2 diabetes mellitus.
Kodani N, Saisho Y, Tanaka K, Kawai T, Itoh H
Clin Drug Investig. 2013; 33(8):563-70.
PMID: 23797928
DOI: 10.1007/s40261-013-0098-5.
Type 2 diabetes in East Asians: similarities and differences with populations in Europe and the United States.
Ma R, Chan J
Ann N Y Acad Sci. 2013; 1281:64-91.
PMID: 23551121
PMC: 3708105.
DOI: 10.1111/nyas.12098.